Macrophage plasticity in experimental atherosclerosis

Jamila Khallou-Laschet1, Aditi Varthaman, Giulia Fornasa

  • 1UMRS698 INSERM, Paris, France.

Plos One
|January 30, 2010
PubMed

Insights

Macrophages (MØ) shift from M2 to M1 phenotypes during atherosclerosis progression in ApoE KO mice. This M2 to M1 switch, driven by cell conversion, suggests targeting MØ phenotype could offer atheroprotective benefits.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Atherosclerosis Pathogenesis

Background:

  • Macrophages (MØ) are key players in atherosclerosis development and progression.
  • Understanding MØ phenotype dynamics is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the phenotype of macrophages associated with atherosclerosis progression in apolipoprotein E (ApoE) knockout (KO) mice.
  • To determine if MØ phenotype switching occurs in vivo and if it is driven by cell conversion.

Main Methods:

  • Utilized bone marrow-derived MØ for in vitro M1/M2 polarization studies.
  • Assessed arginase I (Arg I) and arginase II (Arg II) expression to distinguish M1 and M2 MØ phenotypes.
  • Analyzed MØ distribution in atherosclerotic plaques of ApoE KO mice.
  • Performed in vitro repolarization experiments to assess MØ plasticity.

Main Results:

  • M1 MØ expressed Arg II, while M2 MØ expressed Arg I.
  • Early lesions contained M2 MØ, which promoted smooth muscle cell proliferation in vitro.
  • M1 MØ became dominant in aged ApoE KO mice, correlating with lesion progression.
  • In vitro experiments demonstrated MØ plasticity, with the ability to revert phenotypes.
  • In vivo data suggested M2 to M1 MØ conversion within existing lesions, rather than new M1 MØ recruitment.

Conclusions:

  • The M2 to M1 macrophage phenotype switch in atherosclerosis is likely due to conversion of resident cells, not solely recruitment.
  • Targeting MØ phenotype to promote an M2 phenotype may represent a viable atheroprotective strategy.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...